Effects of Fermented Wheat Germ Extract on Oral Cancer Cells: An In Vitro Study

References

• Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, Carter A, Casey DC, Charlson FJ, Chen AZ, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545–602. doi:10.1016/S0140-6736(16)31678-6
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Mueller T, Jordan K, Voigt W. Promising cytotoxic activity profile of fermented wheat germ extract (Avemar®) in human cancer cell lines. J Exp Clin Cancer Res. 2011;30:42. doi:10.1186/1756-9966-30-42
   PubMed Web of Science ®Google Scholar
• Taghavi N, Yazdi I. Prognostic factors of survival rate in oral squamous cell carcinoma: clinical, histologic, genetic and molecular concepts. Arch Iran Med. 2015;18(5):314–9. doi: 0151805/AIM.0010.
   PubMed Web of Science ®Google Scholar
• Troiano G, Caponio VCA, Adipietro I, Tepedino M, Santoro R, Laino L, Lo Russo L, Cirillo N, Lo Muzio L. Prognostic significance of CD68(+) and CD163(+) tumor associated macrophages in head and neck squamous cell carcinoma: a systematic review and meta-analysis. Oral Oncol. 2019;93:66–75. doi:10.1016/j.oraloncology.2019.04.019
   PubMed Web of Science ®Google Scholar
• Caponio VCA, Troiano G, Adipietro I, Zhurakivska K, Arena C, Mangieri D, Mascitti M, Cirillo N, Lo Muzio L. Computational analysis of TP53 mutational landscape unveils key prognostic signatures and distinct pathobiological pathways in head and neck squamous cell cancer. Br J Cancer. 2020;123:1310–14. doi:10.1038/s41416-020-0984-6
   Web of Science ®Google Scholar
• Troiano G, Caponio VCA, Zhurakivska K, Arena C, Pannone G, Mascitti M, Santarelli A, Lo Muzio L. High PD-L1 expression in the tumour cells did not correlate with poor prognosis of patients suffering for oral squamous cells carcinoma: a meta-analysis of the literature. Cell Prolif. 2019;52(2):e12537. doi:10.1111/cpr.12537
   PubMed Web of Science ®Google Scholar
• Almangush A, Heikkinen I, Bakhti N, Mäkinen LK, Kauppila JH, Pukkila M, Hagström J, Laranne J, Soini Y, Kowalski LP, et al. Prognostic impact of tumour-stroma ratio in early-stage oral tongue cancers. Histopathology. 2018;72(7):1128–35. doi:10.1111/his.13481
   PubMed Web of Science ®Google Scholar
• Rogers SN, Brown JS, Woolgar JA, Lowe D, Magennis P, Shaw RJ, Sutton D, Errington D, Vaughan D. Survival following primary surgery for oral cancer. Oral Oncol. 2009;45(3):201–11. doi:10.1016/j.oraloncology.2008.05.008
   PubMed Web of Science ®Google Scholar
• Mroueh R, Haapaniemi A, Grénman R, Laranne J, Pukkila M, Almangush A, Salo T, Mäkitie A. Improved outcomes with oral tongue squamous cell carcinoma in Finland. Head Neck. 2017;39(7):1306–12. doi:10.1002/hed.24744
   PubMed Web of Science ®Google Scholar
• Lindemann A, Takahashi H, Patel AA, Osman AA, Myers JN. Targeting the DNA damage response in OSCC with TP53 mutations. J Dent Res. 2018;97(6):635–44. doi:10.1177/0022034518759068
   PubMed Web of Science ®Google Scholar
• Shapiro CL. Highlights of recent findings on quality-of-life management for patients with cancer and their survivors. JAMA Oncol. 2016;2(11):1401–2. doi:10.1001/jamaoncol.2016.3620
   PubMed Web of Science ®Google Scholar
• Hidvégi M, Rásó E, Tömösközi-Farkas R, Szende B, Paku S, Prónai L, Bocsi J, Lapis K. MSC, a new benzoquinone-containing natural product with antimetastatic effect. Cancer Biother Radiopharm. 1999;14(4):277–89. doi:10.1089/cbr.1999.14.277
   PubMed Web of Science ®Google Scholar
• Hidvégi M, Ráso E, Tömösközi-Farkas R, Paku S, Lapis K, Szende B. Effect of Avemar and Avemar + vitamin C on tumor growth and metastasis in experimental animals. Anticancer Res. 1998;18(4A):2353–8.
   PubMed Web of Science ®Google Scholar
• Telekes A, Hegedus M, Chae CH, Vekey K. Avemar (wheat germ extract) in cancer prevention and treatment. Nutr Cancer. 2009;61(6):891–9. doi:10.1080/01635580903285114
   PubMed Web of Science ®Google Scholar
• Zhurakivska K, Troiano G, Caponio VCA, Dioguardi M, Arena C, Lo Muzio L. The effects of adjuvant fermented wheat germ extract on cancer cell lines: a systematic review. Nutrients. 2018;10:1546. doi:10.3390/nu10101546
   PubMed Web of Science ®Google Scholar
• Demidov LV, Manziuk LV, Kharkevitch GY, Pirogova NA, Artamonova EV. Adjuvant fermented wheat germ extract (Avemar) nutraceutical improves survival of high-risk skin melanoma patients: a randomized, pilot, phase II clinical study with a 7-year follow-up. Cancer Biother Radiopharm. 2008;23(4):477–82. doi:10.1089/cbr.2008.0486
   PubMed Web of Science ®Google Scholar
• Jakab F, Shoenfeld Y, Balogh Á, Nichelatti M, Hoffmann A, Kahán Z, Lapis K, Mayer Á, Sápy P, Szentpétery F, et al. A medical nutriment has supportive value in the treatment of colorectal cancer. Br J Cancer. 2003;89(3):465–9. doi:10.1038/sj.bjc.6601153
   PubMed Web of Science ®Google Scholar
• Yang M-D, Chang W-S, Tsai C-W, Wang M-F, Chan Y-C, Chan K-C, Lu M-C, Kao A-W, Hsu C-M, Bau D-T, et al. Inhibitory effects of AVEMAR on proliferation and metastasis of oral cancer cells. Nutr Cancer. 2016;68(3):473–80. doi:10.1080/01635581.2016.1153668
   PubMed Web of Science ®Google Scholar
• Kumar P, Nagarajan A, Uchil PD. Analysis of cell viability by the MTT assay. Cold Spring Harb Protoc. 2018;2018(6):095505. doi:10.1101/pdb.prot095505
   Google Scholar
• Naakka E, Tuomainen K, Wistrand H, Palkama M, Suleymanova I, Al-Samadi A, Salo T. Fully human tumor-based matrix in three-dimensional spheroid invasion assay. JoVE. 2019;2019:e59567. doi:10.3791/59567
   Google Scholar
• Salo T, Sutinen M, Hoque Apu E, Sundquist E, Cervigne NK, de Oliveira CE, Akram SU, Ohlmeier S, Suomi F, Eklund L, et al. A novel human leiomyoma tissue derived matrix for cell culture studies. BMC Cancer. 2015;15:981. doi:10.1186/s12885-015-1944-z
   PubMed Web of Science ®Google Scholar
• Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676–82. doi:10.1038/nmeth.2019
   PubMed Web of Science ®Google Scholar
• Salo T, Dourado MR, Sundquist E, Apu EH, Alahuhta I, Tuomainen K, Vasara J, Al-Samadi A. Organotypic three-dimensional assays based on human leiomyoma–derived matrices. Philos Trans R Soc Lond B Biol Sci. 2018;373(1737):20160482.
   PubMedGoogle Scholar
• Zhang J-Y, Xiao X, Dong Y, Wu J, Yao F, Zhou X-H. Effect of fermented wheat germ extract with lactobacillus plantarum dy-1 on HT-29 cell proliferation and apoptosis. J Agric Food Chem. 2015;63(9):2449–57. doi:10.1021/acs.jafc.5b00041
   PubMed Web of Science ®Google Scholar
• Tai C-J, Wang W-C, Wang C-K, Wu C-H, Yang M-D, Chang Y-J, Jian J-Y, Tai C-J. Fermented wheat germ extract induced cell death and enhanced cytotoxicity of Cisplatin and 5-Fluorouracil on human hepatocellular carcinoma cells. Evid Based Complement Alternat Med. 2013;2013:121725. doi:10.1155/2013/121725
   PubMed Web of Science ®Google Scholar
• Xie M, Liu J, Tsao R, Wang Z, Sun B, Wang J. Whole grain consumption for the prevention and treatment of breast cancer. Nutrients. 2019;11:PMC6723813. doi:10.3390/nu11081769
   Web of Science ®Google Scholar
• Vernieri C, Nichetti F, Raimondi A, Pusceddu S, Platania M, Berrino F, de Braud F. Diet and supplements in cancer prevention and treatment: clinical evidences and future perspectives. Crit Rev Oncol Hematol. 2018;123:57–73. doi:10.1016/j.critrevonc.2018.01.002
   PubMed Web of Science ®Google Scholar
• Aquino I. G d, Bastos DC, Cuadra-Zelaya FJM, Teixeira IF, Salo T, Coletta RD, Graner E. Anticancer properties of the fatty acid synthase inhibitor TVB-3166 on oral squamous cell carcinoma cell lines. Arch Oral Biol. 2020;113:104707. doi:10.1016/j.archoralbio.2020.104707
   PubMed Web of Science ®Google Scholar
• Momose F, Araida T, Negishi A, Ichijo H, Shioda S, Sasaki S. Variant sublines with different metastatic potentials selected in nude mice from human oral squamous cell carcinomas. J Oral Pathol Med. 1989;18(7):391–5. doi:10.1111/j.1600-0714.1989.tb01570.x
   PubMed Web of Science ®Google Scholar
• Matsumoto K, Matsumoto K, Nakamura T, Kramer RH. Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J Biol Chem. 1994;269(50):31807–13. doi:10.1016/S0021-9258(18)31767-8
   PubMed Web of Science ®Google Scholar
• Ramos DM, Chen BL, Boylen K, Stern M, Kramer RH, Sheppard D, Nishimura SL, Greenspan D, Zardi L, Pytela R, et al. Stromal fibroblasts influence oral squamous-cell carcinoma cell interactions with tenascin-C. Int J Cancer. 1997;72(2):369–76. doi:10.1002/(sici)1097-0215(19970717)72:2 < 369::aid-ijc28 > 3.0.co;2-9
   PubMed Web of Science ®Google Scholar
• Okumura K, Konishi A, Tanaka M, Kanazawa M, Kogawa K, Niitsu Y. Establishment of high- and low-invasion clones derived for a human tongue squamous-cell carcinoma cell line SAS. J Cancer Res Clin Oncol. 1996;122(4):243–8. doi:10.1007/bf01209653
   PubMed Web of Science ®Google Scholar
• Takahashi K. Establishment and characterization of a cell line (SAS) from poorly defferentiated human squamous cell carcinoma of the tongue. J Jpn Stomatol Soc. 1989;38:20–8.
   Google Scholar
• Teppo S, Sundquist E, Vered M, Holappa H, Parkkisenniemi J, Rinaldi T, Lehenkari P, Grenman R, Dayan D, Risteli J, et al. The hypoxic tumor microenvironment regulates invasion of aggressive oral carcinoma cells. Exp Cell Res. 2013;319(4):376–89. doi:10.1016/j.yexcr.2012.12.010
   PubMed Web of Science ®Google Scholar
• Tuomainen K, Al-Samadi A, Potdar S, Turunen L, Turunen M, Karhemo P-R, Bergman P, Risteli M, Astrom P, Tiikkaja R, et al. Human tumor-derived matrix improves the predictability of head and neck cancer drug testing. Cancers (Basel). 2019;12:92. doi:10.3390/cancers12010092
   PubMed Web of Science ®Google Scholar
• Väyrynen O, Piippo M, Jämsä H, Väisänen T, de Almeida CEB, Salo T, Missailidis S, Risteli M. Effects of ionizing radiation and HPSE1 inhibition on the invasion of oral tongue carcinoma cells on human extracellular matrices in vitro. Exp Cell Res. 2018;371(1):151–61. doi:10.1016/j.yexcr.2018.08.005
   PubMed Web of Science ®Google Scholar
• Vierthaler M, Rodrigues PC, Sundquist E, Siponen M, Salo T, Risteli M. Fluctuating role of antimicrobial peptide hCAP18/LL‑37 in oral tongue dysplasia and carcinoma. Oncol Rep. 2020;44(1):325–38. doi:10.3892/or.2020.7609
   PubMed Web of Science ®Google Scholar
• Dasari S, Tchounwou PB. Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol. 2014;740:364–78. doi:10.1016/j.ejphar.2014.07.025
   PubMed Web of Science ®Google Scholar
• Andreadis C, Vahtsevanos K, Sidiras T, Thomaidis I, Antoniadis K, Mouratidou D. 5-Fluorouracil and cisplatin in the treatment of advanced oral cancer. Oral Oncol. 2003;39(4):380–5. doi:10.1016/s1368-8375(02)00141-0
   PubMed Web of Science ®Google Scholar
• Su L, Wang Y, Xiao M, Lin Y, Yu L. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110:484–91. doi:10.1016/j.tripleo.2010.04.009
   PubMed Web of Science ®Google Scholar
• Shim HJ, Kim HJ, Hwang JE, Bae WK, Chung IJ, Lee DH, Mi YT, Lee JK, Lim SC, Chung JW, et al. Long term complications and prognostic factors in locally advanced nasopharyngeal carcinoma treated with docetaxel, cisplatin, 5-fluorouracil induction chemotherapy followed by concurrent chemoradiotherapy: a retrospective cohort study. Medicine (Baltimore). 2020;99(49):e23173:doi:10.1097/md.0000000000023173
   PubMed Web of Science ®Google Scholar
• Pons-Fuster López E, Gómez García F, López Jornet P. Combination of 5-florouracil and polyphenol EGCG exerts suppressive effects on oral cancer cells exposed to radiation. Arch Oral Biol. 2019;101:8–12. doi:10.1016/j.archoralbio.2019.02.018
   PubMed Web of Science ®Google Scholar
• Kim EH, Jang H, Shin D, Baek SH, Roh JL. Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer. Apoptosis. 2016;21(11):1265–78. doi:10.1007/s10495-016-1284-8
   PubMed Web of Science ®Google Scholar